Skip to main content

previous disabled Page of 5
and
  1. Article

    Publisher Correction: E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1

    Chun-yan Duan, Yue Li, Hao-yu Zhi, Yao Tian, Zheng-yun Huang in Acta Pharmacologica Sinica (2024)

  2. No Access

    Article

    E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1

    The circadian clock is the inner rhythm of life activities and is controlled by a self-sustained and endogenous molecular clock, which maintains a ~ 24 h internal oscillation. As the core element of the circad...

    Chun-yan Duan, Yue Li, Hao-yu Zhi, Yao Tian, Zheng-yun Huang in Acta Pharmacologica Sinica (2024)

  3. No Access

    Article

    A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer

    Antibody drug conjugate (ADC) therapy has become one of the most promising approaches in cancer immunotherapy. Bispecific targeting could enhance the efficacy and safety of ADC by improving its specificity, af...

    Hui-fang Zong, ** Li, Lei Han, Lei Wang, Jun-jun Liu in Acta Pharmacologica Sinica (2024)

  4. Article

    Open Access

    Identification of immune-associated biomarker for predicting lung adenocarcinoma: bioinformatics analysis and experiment verification of PTK6

    Abnormal expression of protein tyrosine kinase 6 (PTK6) has been proven to be involved in the development of gynecological tumors. However, its immune-related carcinogenic mechanism in other tumors remains unc...

    Ren-Hui **ong, Shuo-Qi Yang, Ji-Wei Li, Xun-kai Shen, Lu-Ming ** in Discover Oncology (2024)

  5. Article

    Open Access

    Adeno-associated virus as a delivery vector for gene therapy of human diseases

    Adeno-associated virus (AAV) has emerged as a pivotal delivery tool in clinical gene therapy owing to its minimal pathogenicity and ability to establish long-term gene expression in different tissues. Recombin...

    Jiang-Hui Wang, Dominic J. Gessler, Wei Zhan in Signal Transduction and Targeted Therapy (2024)

  6. Article

    Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition

    Kai-long Jiang, Chang-mei Liu, Li-tong Nie, Hai-ni Jiang in Acta Pharmacologica Sinica (2023)

  7. Article

    Open Access

    ALOX5AP is a new prognostic indicator in acute myeloid leukemia

    The overexpression of ALOX5AP has been observed in many types of cancer and has been identified as an oncogene. However, its role in acute myeloid leukemia (AML) has not been extensively studied. This study ai...

    **n-Yi Chen, **ang-Mei Wen, Wei Zhao, Ming-Qiang Chu, Yu Gu in Discover Oncology (2023)

  8. Article

    Open Access

    Metatranscriptome of human lung microbial communities in a cohort of mechanically ventilated COVID-19 Omicron patients

    The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infected a substantial proportion of Chinese population, and understanding the factors underlying the severity of the dis...

    Lin Wang, Jia-Bao Cao, Bin-Bin **a, Yue-Juan Li in Signal Transduction and Targeted Therapy (2023)

  9. Article

    Open Access

    Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease

    Sex and reproductive status differences exist in both non-alcoholic fatty liver disease (NAFLD) and body composition. Our purpose was to investigate the relationship between body composition and the severity o...

    Yu-tian Cao, Wen-hui Zhang, Yan Lou, Qian-hua Yan, Yu-juan Zhang in BMC Gastroenterology (2023)

  10. No Access

    Article

    TFEB: a double-edged sword for tumor metastasis

    Transcription factor EB, a member of the microphthalmia-associated transcription factor (MiTF/TFE) family, is a master regulator of autophagy, lysosome biogenesis, and TAMs. Metastasis is one of the main reaso...

    Jun-Hu Hu, Shou-Ye Li, Li-Hua Yu, Zhen-Rong Guan in Journal of Molecular Medicine (2023)

  11. Article

    Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktails

    The continuous emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants poses challenges to the effectiveness of neutralizing antibodies. Rational design of antibody cocktails is a re...

    Hang Ma, Hui-fang Zong, Jun-jun Liu, Ya-li Yue, Yong Ke in Acta Pharmacologica Sinica (2023)

  12. Article

    Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice

    Aristolochic acid I (AAI) is a well established nephrotoxin and human carcinogen. Cytosolic NAD(P)H quinone oxidoreductase 1 (NQO1) plays an important role in the nitro reduction of aristolochic acids, leading...

    Ya-** Dong, Shu-zhen Chen, Hui-si He, Zhuo-ran Sun in Acta Pharmacologica Sinica (2023)

  13. Article

    Open Access

    LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway

    LZTFL1 is a tumor suppressor located in chromosomal region 3p21.3 that is deleted frequently and early in various cancer types including the kidney cancer. However, its role in kidney tumorigenesis remains unk...

    Jun Lu, Liang-min Fu, Yun Cao, Yong Fang, Jia-zheng Cao, Yi-hui Pan in Oncogene (2023)

  14. No Access

    Article

    Discovery and characterization of a novel cGAS covalent inhibitor for the treatment of inflammatory bowel disease

    Cyclic GMP-AMP synthase (cGAS), a cytosolic DNA sensor, acts as a nucleotidyl transferase that catalyzes ATP and GTP to form cyclic GMP-AMP (cGAMP) and plays a critical role in innate immunity. Hyperactivation...

    Jia Song, Rui-rui Yang, Jie Chang, Ya-dan Liu, Cheng-hao Lu in Acta Pharmacologica Sinica (2023)

  15. No Access

    Article

    Discovery and identification of a novel small molecule BCL-2 inhibitor that binds to the BH4 domain

    The B-cell lymphoma 2 (BCL-2) protein family plays a pivotal role in regulating the apoptosis process. BCL-2, as an antiapoptotic protein in this family, mediates apoptosis resistance and is an ideal target fo...

    **g-yi Zhou, Rui-rui Yang, Jie Chang, Jia Song, Zi-sheng Fan in Acta Pharmacologica Sinica (2023)

  16. Article

    Open Access

    Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma

    The patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL) have poor prognosis, and a novel and effective therapeutic strategy for these patients is urgently needed. Although ubiquitin-spe...

    **-Ya Li, Ji-Chuan Wu, ** Liu, Zi-Juan Li, Yong Wang, Bing-Yi Chen in Leukemia (2023)

  17. Article

    Open Access

    Risk Factors for Glycemic Control in Hospitalized Patients with Type 2 Diabetes Receiving Continuous Subcutaneous Insulin Infusion Therapy

    Patients with diabetes are confronted with numerous obstacles to achieve adequate glycemic control during hospitalization. The aim of this study was to explore the risk factors associated with glycemic control...

    Shun-hua Wang, Wei Shao, Qiu-hui Jiang, Xuan-ling Zheng, Qing-bao Shen in Diabetes Therapy (2023)

  18. No Access

    Article

    Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition

    Inositol-requiring enzyme 1α (IRE1α) is the most conserved endoplasmic reticulum (ER) stress sensor with two catalytic domains, kinase and RNase, in its cytosolic portion. IRE1α inhibitors have been used to im...

    Kai-long Jiang, Chang-mei Liu, Li-tong Nie, Hai-ni Jiang in Acta Pharmacologica Sinica (2023)

  19. Article

    Open Access

    Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects

    VV116 (JT001) is an oral drug candidate of nucleoside analog against SARS-CoV-2. The purpose of the three phase I studies was to evaluate the safety, tolerability, and pharmacokinetics of single and multiple a...

    Hong-jie Qian, Yu Wang, Meng-qi Zhang, Yuan-chao **e in Acta Pharmacologica Sinica (2022)

  20. No Access

    Article

    Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses

    To explore the diagnostic performance of EFSUMB CEUS Pancreatic Applications guidelines (version 2017) before and after the addition of iso-enhancement and very fast/fast washout as supplementary diagnostic cr...

    Wan-ying Jia, Yang Gui, Xue-qi Chen, **ao-qian Zhang, Jia-hui Zhang in European Radiology (2022)

previous disabled Page of 5